Retention on lifelong antiretroviral therapy (ART) is essential in sustaining treatment success while preventing HIV drug resistance (HIVDR), especially in resource-limited settings (RLS). In an era of rising numbers of patients on ART, mastering patients in care is becoming more strategic for programmatic interventions. Due to lapses and uncertainty with the current WHO sampling approach in Cameroon, we thus aimed to ascertain the national performance of, and determinants in, retention on ART at 12 months.
Billong, S., Fokam, J., Penda, C., Amadou, S., Kob, D., Billong, E., et al. (2016). Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: Results from a nationwide systematic random sampling. BMC INFECTIOUS DISEASES, 16(1), 678 [10.1186/s12879-016-1991-3].
Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: Results from a nationwide systematic random sampling
COLIZZI, VITTORIO;
2016-01-01
Abstract
Retention on lifelong antiretroviral therapy (ART) is essential in sustaining treatment success while preventing HIV drug resistance (HIVDR), especially in resource-limited settings (RLS). In an era of rising numbers of patients on ART, mastering patients in care is becoming more strategic for programmatic interventions. Due to lapses and uncertainty with the current WHO sampling approach in Cameroon, we thus aimed to ascertain the national performance of, and determinants in, retention on ART at 12 months.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
